The role of heterotrimeric G proteins in the signaling of Wnts has been established, from flies to mammals. Wnts signal, in part, via heptahelical G protein coupled receptors (GPCR) to effectors systems that control fundamental processes, such as adipogenesis, bone formation, cell progression, cell fate, and other aspects of early development. Dysregulation of Wot signaling provides a basis for human disease, including cancer. The phosphoprotein Dishevelled (Dvl) is essential to Wnt/p-catenin (canonical), Wnt/Ca2+/cGMP, and Wnt/planar cell polarity (PCP) pathways. Wnts promote mouse F9 embryonic teratocarcinoma cells (F9) to primitive endoderm (PE) and activate each of these effector pathways, via 1/more of 3 mammalian Dvls. We propose 3 specific aims: (i) to define functional roles of mammalian Dvls on each major Wnt-stimulated pathway using siRNA and read outs of p-catenin stability, Lef/Tcf-sensitive transcription, Ca2+ imaging and cGMP analysis, INK activation via Rho, and PE formation;(ii) to establish multivalency of Dvl interactions with GPCR, G proteins, kinases/phosphatases, and adaptor molecules critical to Wnt signaling making use of tandem affinity-based purification (TAP) and advanced proteomics (M ALDI, QToF, and nanospray mass spectrometry), siRNA-based knock downs, enzyme inhibitors/dominant negative constructs, and eventual mutagenesis of potential docking sites;and (iii) to establish the functional consequences of spatial localization and trafficking of Dvl in na'ive and Wnt-activated F9 cells, focusing on defining the dynamic aspects of activation /deactivation using fluorescence-based strategies (including 2-photon,/cs, and TIRF microscopy), energy transfer measurements In live cells (via BRET), and cell fractionation coupled with TAP-tagged Dvl followed by proteomics. The overarching hypothesis is that Dvls function as dynamic scaffolds for integration of cell signaling to a spectrum of diverse pathways, much like the AKAP protein family members function. Dvls both dock and are candidate substrates for many kinases/phosphatases, although the details of these interactive regulations remain to be established by proteomics. Real-time measurements of docking in live cells are made possible by BRET and parallel biochemical /proteomics assays that can define the status of Dvl with respect to protein phosphorylation. The functional basis for 3 mammalian Dvls, for their spatial and temporal trafficking, and for cell membrane association are addressed using in vivo and in vitro strategies. Understanding the multivalency and docking of Dvl open opportunity to intervene in the primary signaling pathways controlled by Wnts, including those whose dysregulation leads to cancer, birth defects, and altered bone formation. Dvls, as multivalent dynamic scaffolds, are high-value likely targets for new therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030111-27
Application #
7568825
Study Section
Development - 2 Study Section (DEV2)
Program Officer
Blondel, Olivier
Project Start
1981-08-01
Project End
2011-01-31
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
27
Fiscal Year
2009
Total Cost
$374,964
Indirect Cost
Name
State University New York Stony Brook
Department
Pharmacology
Type
Schools of Medicine
DUNS #
804878247
City
Stony Brook
State
NY
Country
United States
Zip Code
11794
Bikkavilli, Rama Kamesh; Avasarala, Sreedevi; Vanscoyk, Michelle et al. (2012) Dishevelled3 is a novel arginine methyl transferase substrate. Sci Rep 2:805
Bikkavilli, Rama Kamesh; Malbon, Craig C (2012) Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2. J Cell Sci 125:2446-56
Wang, H-Y; Malbon, C C (2012) Dishevelled C-terminus: prolyl and histidinyl motifs. Acta Physiol (Oxf) 204:65-73
Malbon, Craig C (2011) Wnt signalling: the case of the 'missing' G-protein. Biochem J 433:e3-5
Bikkavilli, Rama Kamesh; Malbon, Craig C (2011) Arginine methylation of G3BP1 in response to Wnt3a regulates ?-catenin mRNA. J Cell Sci 124:2310-20
Chen, Min-Huei; Malbon, Craig C (2009) G-protein-coupled receptor-associated A-kinase anchoring proteins AKAP5 and AKAP12: differential trafficking and distribution. Cell Signal 21:136-42
Bikkavilli, Rama Kamesh; Feigin, Michael E; Malbon, Craig C (2008) p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. J Cell Sci 121:3598-607
Bikkavilli, Rama Kamesh; Feigin, Michael E; Malbon, Craig C (2008) G alpha o mediates WNT-JNK signaling through dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells. J Cell Sci 121:234-45
Feigin, Michael E; Malbon, Craig C (2008) OSTM1 regulates beta-catenin/Lef1 interaction and is required for Wnt/beta-catenin signaling. Cell Signal 20:949-57
Gavi, Shai; Shumay, Elena; Wang, Hsien-yu et al. (2006) G-protein-coupled receptors and tyrosine kinases: crossroads in cell signaling and regulation. Trends Endocrinol Metab 17:48-54

Showing the most recent 10 out of 67 publications